

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement (GO:0003351) | 4.97170275 |
| 2 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.90727189 |
| 3 | cilium movement (GO:0003341) | 4.78554783 |
| 4 | positive regulation of mitochondrial fission (GO:0090141) | 4.67504938 |
| 5 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.53829290 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 3.92781212 |
| 7 | central nervous system myelination (GO:0022010) | 3.92781212 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 3.81080310 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 3.74271475 |
| 10 | cilium organization (GO:0044782) | 3.72329619 |
| 11 | axonemal dynein complex assembly (GO:0070286) | 3.70793743 |
| 12 | cilium assembly (GO:0042384) | 3.65775419 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.64940505 |
| 14 | regulation of cilium movement (GO:0003352) | 3.63218191 |
| 15 | presynaptic membrane assembly (GO:0097105) | 3.53205327 |
| 16 | DNA integration (GO:0015074) | 3.43541923 |
| 17 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.43258669 |
| 18 | intraciliary transport (GO:0042073) | 3.41620505 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.39548694 |
| 20 | chaperone-mediated protein transport (GO:0072321) | 3.37042021 |
| 21 | synaptic vesicle maturation (GO:0016188) | 3.33401161 |
| 22 | cullin deneddylation (GO:0010388) | 3.26568150 |
| 23 | left/right axis specification (GO:0070986) | 3.24897398 |
| 24 | presynaptic membrane organization (GO:0097090) | 3.22089825 |
| 25 | glutamate secretion (GO:0014047) | 3.20631730 |
| 26 | platelet dense granule organization (GO:0060155) | 3.14714858 |
| 27 | microtubule depolymerization (GO:0007019) | 3.13282720 |
| 28 | protein deneddylation (GO:0000338) | 3.12077349 |
| 29 | postsynaptic membrane organization (GO:0001941) | 3.09136306 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.08073047 |
| 31 | protein localization to synapse (GO:0035418) | 3.06629672 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 3.02532227 |
| 33 | negative regulation of neurotransmitter transport (GO:0051589) | 3.01831888 |
| 34 | neural tube formation (GO:0001841) | 2.99696274 |
| 35 | neurofilament cytoskeleton organization (GO:0060052) | 2.98653227 |
| 36 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.98256088 |
| 37 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.94730612 |
| 38 | nucleobase catabolic process (GO:0046113) | 2.92906388 |
| 39 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92106289 |
| 40 | behavioral response to ethanol (GO:0048149) | 2.91385569 |
| 41 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.91079996 |
| 42 | retinal rod cell development (GO:0046548) | 2.87474297 |
| 43 | neuron recognition (GO:0008038) | 2.86503230 |
| 44 | axonal fasciculation (GO:0007413) | 2.86394635 |
| 45 | photoreceptor cell differentiation (GO:0046530) | 2.86196731 |
| 46 | eye photoreceptor cell differentiation (GO:0001754) | 2.86196731 |
| 47 | apical protein localization (GO:0045176) | 2.86122144 |
| 48 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.83755573 |
| 49 | regulation of mitochondrial fission (GO:0090140) | 2.81994176 |
| 50 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.81978079 |
| 51 | retinal cone cell development (GO:0046549) | 2.78578141 |
| 52 | negative regulation of axon guidance (GO:1902668) | 2.76921490 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76501199 |
| 54 | establishment of mitochondrion localization (GO:0051654) | 2.75054165 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 2.74967093 |
| 56 | spermatid nucleus differentiation (GO:0007289) | 2.73789453 |
| 57 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.72539839 |
| 58 | protein polyglutamylation (GO:0018095) | 2.69691361 |
| 59 | fatty acid elongation (GO:0030497) | 2.68865867 |
| 60 | innervation (GO:0060384) | 2.68712460 |
| 61 | positive regulation of steroid hormone secretion (GO:2000833) | 2.67129610 |
| 62 | detection of calcium ion (GO:0005513) | 2.66850767 |
| 63 | anterograde synaptic vesicle transport (GO:0048490) | 2.65480376 |
| 64 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.65443529 |
| 65 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.62675727 |
| 66 | inositol phosphate catabolic process (GO:0071545) | 2.62674512 |
| 67 | respiratory chain complex IV assembly (GO:0008535) | 2.62662388 |
| 68 | retinal ganglion cell axon guidance (GO:0031290) | 2.62355425 |
| 69 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.62024862 |
| 70 | protein complex biogenesis (GO:0070271) | 2.61147643 |
| 71 | protein localization to cilium (GO:0061512) | 2.60293864 |
| 72 | sequestering of actin monomers (GO:0042989) | 2.59895905 |
| 73 | establishment of synaptic vesicle localization (GO:0097480) | 2.58863133 |
| 74 | synaptic vesicle transport (GO:0048489) | 2.58863133 |
| 75 | determination of left/right symmetry (GO:0007368) | 2.58490090 |
| 76 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.58296985 |
| 77 | photoreceptor cell maintenance (GO:0045494) | 2.57576991 |
| 78 | C-terminal protein lipidation (GO:0006501) | 2.57338077 |
| 79 | limb bud formation (GO:0060174) | 2.56942041 |
| 80 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.55943400 |
| 81 | inositol phosphate dephosphorylation (GO:0046855) | 2.55943400 |
| 82 | determination of bilateral symmetry (GO:0009855) | 2.54615519 |
| 83 | response to auditory stimulus (GO:0010996) | 2.53426518 |
| 84 | left/right pattern formation (GO:0060972) | 2.53012854 |
| 85 | regulation of vesicle fusion (GO:0031338) | 2.52903262 |
| 86 | behavioral response to nicotine (GO:0035095) | 2.52297936 |
| 87 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.52062700 |
| 88 | proteasome assembly (GO:0043248) | 2.51700655 |
| 89 | synaptic transmission, glutamatergic (GO:0035249) | 2.50125968 |
| 90 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.49523114 |
| 91 | specification of symmetry (GO:0009799) | 2.49423981 |
| 92 | protein neddylation (GO:0045116) | 2.49110886 |
| 93 | anterograde axon cargo transport (GO:0008089) | 2.48891356 |
| 94 | regulation of glucokinase activity (GO:0033131) | 2.48863078 |
| 95 | regulation of hexokinase activity (GO:1903299) | 2.48863078 |
| 96 | dendrite morphogenesis (GO:0048813) | 2.48231119 |
| 97 | asymmetric protein localization (GO:0008105) | 2.48095429 |
| 98 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.47513506 |
| 99 | substantia nigra development (GO:0021762) | 2.47325183 |
| 100 | regulation of action potential (GO:0098900) | 2.47215332 |
| 101 | C-terminal protein amino acid modification (GO:0018410) | 2.45622302 |
| 102 | axoneme assembly (GO:0035082) | 2.45524276 |
| 103 | type B pancreatic cell proliferation (GO:0044342) | 2.44290912 |
| 104 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.43402508 |
| 105 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.42507425 |
| 106 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.42397194 |
| 107 | positive regulation of action potential (GO:0045760) | 2.42226923 |
| 108 | glutamate receptor signaling pathway (GO:0007215) | 2.42129920 |
| 109 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.42082763 |
| 110 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.41845177 |
| 111 | establishment of vesicle localization (GO:0051650) | 2.41561154 |
| 112 | microtubule-based movement (GO:0007018) | 2.41336303 |
| 113 | neuron-neuron synaptic transmission (GO:0007270) | 2.40888122 |
| 114 | vocalization behavior (GO:0071625) | 2.40527780 |
| 115 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.39857033 |
| 116 | vascular smooth muscle contraction (GO:0014829) | 2.39606259 |
| 117 | cilium morphogenesis (GO:0060271) | 2.38982183 |
| 118 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.38808012 |
| 119 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.38761708 |
| 120 | protein localization to Golgi apparatus (GO:0034067) | 2.38317318 |
| 121 | transmission of nerve impulse (GO:0019226) | 2.38257770 |
| 122 | regulation of feeding behavior (GO:0060259) | 2.38109963 |
| 123 | smoothened signaling pathway (GO:0007224) | 2.38004038 |
| 124 | ventricular system development (GO:0021591) | 2.37277373 |
| 125 | negative regulation of neurological system process (GO:0031645) | 2.36134934 |
| 126 | establishment of protein localization to Golgi (GO:0072600) | 2.35683081 |
| 127 | regulation of chronic inflammatory response (GO:0002676) | 2.35633753 |
| 128 | sperm motility (GO:0030317) | 2.35258305 |
| 129 | microtubule bundle formation (GO:0001578) | 2.35061855 |
| 130 | dendrite development (GO:0016358) | 2.34661400 |
| 131 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.34457614 |
| 132 | cytochrome complex assembly (GO:0017004) | 2.34087357 |
| 133 | mannosylation (GO:0097502) | 2.33687981 |
| 134 | regulation of neurotransmitter secretion (GO:0046928) | 2.33670192 |
| 135 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.33110463 |
| 136 | negative chemotaxis (GO:0050919) | 2.32996534 |
| 137 | neurotransmitter uptake (GO:0001504) | 2.32713569 |
| 138 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.32702232 |
| 139 | nonmotile primary cilium assembly (GO:0035058) | 2.32201594 |
| 140 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.32141595 |
| 141 | regulation of dopamine metabolic process (GO:0042053) | 2.31938854 |
| 142 | regulation of catecholamine metabolic process (GO:0042069) | 2.31938854 |
| 143 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.31789470 |
| 144 | mechanosensory behavior (GO:0007638) | 2.30983923 |
| 145 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.30319271 |
| 146 | auditory behavior (GO:0031223) | 2.30179311 |
| 147 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.29689023 |
| 148 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.29294538 |
| 149 | microtubule-based transport (GO:0010970) | 2.28101241 |
| 150 | response to pheromone (GO:0019236) | 2.27937983 |
| 151 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.27671993 |
| 152 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.27268971 |
| 153 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.27176557 |
| 154 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.27153596 |
| 155 | brain morphogenesis (GO:0048854) | 2.26714304 |
| 156 | Golgi to plasma membrane protein transport (GO:0043001) | 2.26565876 |
| 157 | ubiquinone metabolic process (GO:0006743) | 2.26107902 |
| 158 | rRNA methylation (GO:0031167) | 2.25647372 |
| 159 | long-term synaptic potentiation (GO:0060291) | 2.25569827 |
| 160 | microtubule severing (GO:0051013) | 2.25550388 |
| 161 | negative regulation of cation channel activity (GO:2001258) | 2.24907137 |
| 162 | keratinocyte development (GO:0003334) | 2.24270025 |
| 163 | regulation of neuron projection regeneration (GO:0070570) | 2.24224279 |
| 164 | regulation of axon regeneration (GO:0048679) | 2.24224279 |
| 165 | myelination (GO:0042552) | 2.24013852 |
| 166 | gamma-aminobutyric acid transport (GO:0015812) | 2.23717775 |
| 167 | regulation of neurotransmitter transport (GO:0051588) | 2.23397321 |
| 168 | regulation of synapse structural plasticity (GO:0051823) | 2.23222675 |
| 169 | negative regulation of dendrite development (GO:2000171) | 2.22974006 |
| 170 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.22725846 |
| 171 | regulation of protein targeting to membrane (GO:0090313) | 2.22611144 |
| 172 | fibroblast migration (GO:0010761) | 2.22027595 |
| 173 | positive regulation of synapse assembly (GO:0051965) | 2.21956247 |
| 174 | protein targeting to Golgi (GO:0000042) | 2.20924713 |
| 175 | neurotransmitter secretion (GO:0007269) | 2.20467155 |
| 176 | synapse assembly (GO:0007416) | 2.20037685 |
| 177 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.19721830 |
| 178 | establishment of nucleus localization (GO:0040023) | 2.19448867 |
| 179 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.19416552 |
| 180 | GPI anchor metabolic process (GO:0006505) | 2.18486301 |
| 181 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.18193885 |
| 182 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.17765807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.51469894 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.28441862 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.04869129 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.82923467 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.54519707 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.45598695 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32608736 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.27147200 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26509678 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.13318743 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11438282 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08700658 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05787331 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.02116619 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.01055693 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00693435 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98972714 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98849061 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97709051 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95839954 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91071580 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90502758 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90502758 |
| 24 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.90497391 |
| 25 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.89580231 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85968124 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.85934632 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85864765 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85485927 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.80505545 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.79049260 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78892905 |
| 33 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77572109 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77166846 |
| 35 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.76121776 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75602991 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72667999 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71425604 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70080840 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69145766 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68713932 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67014951 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65959901 |
| 44 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.64752440 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64599181 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58045140 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.54258663 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48059222 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47254568 |
| 50 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.47237729 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45636873 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44909117 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44675017 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44654406 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43463051 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43202460 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43051655 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41746665 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40589904 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.40246691 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.38108012 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37581961 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37481788 |
| 64 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.37463600 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36466377 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33919888 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33241734 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33204148 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32024217 |
| 70 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31466597 |
| 71 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29318054 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28964965 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28500283 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.27214114 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.26743088 |
| 76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.26443991 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26081942 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25438622 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25019103 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24721676 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23613990 |
| 82 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.23104866 |
| 83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22733531 |
| 84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20031316 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19490446 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19373781 |
| 87 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.18981990 |
| 88 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.18653687 |
| 89 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.18419109 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17726811 |
| 91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17515139 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16777400 |
| 93 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16599806 |
| 94 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.15907586 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15876363 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15876363 |
| 97 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13834209 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13634206 |
| 99 | JUN_21703547_ChIP-Seq_K562_Human | 1.13357937 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12910043 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12351287 |
| 102 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12233671 |
| 103 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11390674 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11313106 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11224610 |
| 106 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11215931 |
| 107 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11044173 |
| 108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10739624 |
| 109 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.10157633 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09141885 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08929284 |
| 112 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08396818 |
| 113 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07661739 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07545574 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07324591 |
| 116 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.07217789 |
| 117 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06822337 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06287770 |
| 119 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06038902 |
| 120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05914296 |
| 121 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05012731 |
| 122 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04832433 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04584161 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04257022 |
| 125 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.02801165 |
| 126 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02727361 |
| 127 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02351962 |
| 128 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02033231 |
| 129 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.01704224 |
| 130 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.01575614 |
| 131 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01510275 |
| 132 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00475349 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00260160 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00260160 |
| 135 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.00195898 |
| 136 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00098643 |
| 137 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00098643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.92100298 |
| 2 | MP0004270_analgesia | 3.37587442 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.28847120 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.23515917 |
| 5 | MP0005646_abnormal_pituitary_gland | 2.86430235 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.49422175 |
| 7 | MP0001986_abnormal_taste_sensitivity | 2.36525742 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 2.27966287 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.27742268 |
| 10 | MP0006276_abnormal_autonomic_nervous | 2.26324162 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.23467929 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.22345492 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.18499443 |
| 14 | MP0000778_abnormal_nervous_system | 2.13095497 |
| 15 | MP0002064_seizures | 2.09812621 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.06855854 |
| 17 | MP0002234_abnormal_pharynx_morphology | 2.06501290 |
| 18 | MP0009745_abnormal_behavioral_response | 2.04249157 |
| 19 | MP0002272_abnormal_nervous_system | 2.00688480 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.00673876 |
| 21 | MP0002736_abnormal_nociception_after | 1.99608370 |
| 22 | MP0002102_abnormal_ear_morphology | 1.98131000 |
| 23 | MP0001905_abnormal_dopamine_level | 1.96904429 |
| 24 | MP0003122_maternal_imprinting | 1.86696846 |
| 25 | MP0005187_abnormal_penis_morphology | 1.86038525 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.86000945 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.84598432 |
| 28 | MP0009046_muscle_twitch | 1.81575168 |
| 29 | MP0001486_abnormal_startle_reflex | 1.81152087 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.80756392 |
| 31 | MP0004043_abnormal_pH_regulation | 1.79977594 |
| 32 | MP0006054_spinal_hemorrhage | 1.78054775 |
| 33 | MP0004858_abnormal_nervous_system | 1.77387447 |
| 34 | MP0001529_abnormal_vocalization | 1.77060897 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.76218327 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.67402697 |
| 37 | MP0001970_abnormal_pain_threshold | 1.67047973 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.65125649 |
| 39 | MP0002822_catalepsy | 1.64669247 |
| 40 | MP0001188_hyperpigmentation | 1.64158363 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.64126029 |
| 42 | MP0005171_absent_coat_pigmentation | 1.63352869 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.63034445 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.60916241 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.60137087 |
| 46 | MP0002557_abnormal_social/conspecific_i | 1.52114222 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.51106429 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.48846346 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.46300596 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.45683587 |
| 51 | MP0000427_abnormal_hair_cycle | 1.43257972 |
| 52 | MP0000955_abnormal_spinal_cord | 1.42866777 |
| 53 | MP0002184_abnormal_innervation | 1.42862703 |
| 54 | MP0002282_abnormal_trachea_morphology | 1.42343143 |
| 55 | MP0004133_heterotaxia | 1.42338188 |
| 56 | MP0000631_abnormal_neuroendocrine_gland | 1.42149550 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.41338456 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.39741563 |
| 59 | MP0003329_amyloid_beta_deposits | 1.38871743 |
| 60 | MP0000920_abnormal_myelination | 1.37101895 |
| 61 | MP0001984_abnormal_olfaction | 1.34191590 |
| 62 | MP0002938_white_spotting | 1.34095093 |
| 63 | MP0000647_abnormal_sebaceous_gland | 1.31193882 |
| 64 | MP0002928_abnormal_bile_duct | 1.30823568 |
| 65 | MP0003634_abnormal_glial_cell | 1.29274208 |
| 66 | MP0004142_abnormal_muscle_tone | 1.27082589 |
| 67 | MP0005253_abnormal_eye_physiology | 1.26575832 |
| 68 | MP0008569_lethality_at_weaning | 1.26483747 |
| 69 | MP0002233_abnormal_nose_morphology | 1.25713243 |
| 70 | MP0000372_irregular_coat_pigmentation | 1.25368241 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.24579278 |
| 72 | MP0001299_abnormal_eye_distance/ | 1.24112322 |
| 73 | MP0001485_abnormal_pinna_reflex | 1.23631226 |
| 74 | MP0004924_abnormal_behavior | 1.23366026 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.23366026 |
| 76 | MP0002163_abnormal_gland_morphology | 1.23251784 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.23035713 |
| 78 | MP0002160_abnormal_reproductive_system | 1.21953771 |
| 79 | MP0004215_abnormal_myocardial_fiber | 1.19813180 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 1.19397022 |
| 81 | MP0004885_abnormal_endolymph | 1.18629179 |
| 82 | MP0001348_abnormal_lacrimal_gland | 1.16720113 |
| 83 | MP0001501_abnormal_sleep_pattern | 1.16454853 |
| 84 | MP0004811_abnormal_neuron_physiology | 1.16078401 |
| 85 | MP0008058_abnormal_DNA_repair | 1.16028586 |
| 86 | MP0002229_neurodegeneration | 1.13430192 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 1.12196561 |
| 88 | MP0002909_abnormal_adrenal_gland | 1.11240752 |
| 89 | MP0003937_abnormal_limbs/digits/tail_de | 1.09925885 |
| 90 | MP0008995_early_reproductive_senescence | 1.08112007 |
| 91 | MP0001293_anophthalmia | 1.06512468 |
| 92 | MP0002752_abnormal_somatic_nervous | 1.04575237 |
| 93 | MP0000516_abnormal_urinary_system | 1.03098769 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 1.03098769 |
| 95 | MP0004147_increased_porphyrin_level | 1.02957532 |
| 96 | MP0002751_abnormal_autonomic_nervous | 1.01935523 |
| 97 | MP0000639_abnormal_adrenal_gland | 1.00030949 |
| 98 | MP0003186_abnormal_redox_activity | 0.99718032 |
| 99 | MP0002152_abnormal_brain_morphology | 0.98470367 |
| 100 | MP0005409_darkened_coat_color | 0.96825282 |
| 101 | MP0000534_abnormal_ureter_morphology | 0.95968055 |
| 102 | MP0005391_vision/eye_phenotype | 0.95646791 |
| 103 | MP0005394_taste/olfaction_phenotype | 0.95553660 |
| 104 | MP0005499_abnormal_olfactory_system | 0.95553660 |
| 105 | MP0002090_abnormal_vision | 0.95432388 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.95063955 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.94245387 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 0.93558125 |
| 109 | MP0003633_abnormal_nervous_system | 0.92137283 |
| 110 | MP0000681_abnormal_thyroid_gland | 0.91830493 |
| 111 | MP0001963_abnormal_hearing_physiology | 0.91764230 |
| 112 | MP0004484_altered_response_of | 0.89660191 |
| 113 | MP0003195_calcinosis | 0.88481696 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.87634422 |
| 115 | MP0000751_myopathy | 0.87555126 |
| 116 | MP0003879_abnormal_hair_cell | 0.87131398 |
| 117 | MP0003787_abnormal_imprinting | 0.86987824 |
| 118 | MP0003755_abnormal_palate_morphology | 0.86493689 |
| 119 | MP0009697_abnormal_copulation | 0.86452460 |
| 120 | MP0003631_nervous_system_phenotype | 0.85466427 |
| 121 | MP0001177_atelectasis | 0.85314846 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.85271562 |
| 123 | MP0009250_abnormal_appendicular_skeleto | 0.84856079 |
| 124 | MP0004742_abnormal_vestibular_system | 0.84679432 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.81534154 |
| 126 | MP0003136_yellow_coat_color | 0.81062529 |
| 127 | MP0003011_delayed_dark_adaptation | 0.77859271 |
| 128 | MP0003942_abnormal_urinary_system | 0.77578337 |
| 129 | MP0005389_reproductive_system_phenotype | 0.77522108 |
| 130 | MP0001324_abnormal_eye_pigmentation | 0.77340043 |
| 131 | MP0002837_dystrophic_cardiac_calcinosis | 0.76706111 |
| 132 | MP0000026_abnormal_inner_ear | 0.76344490 |
| 133 | MP0001664_abnormal_digestion | 0.76192068 |
| 134 | MP0003121_genomic_imprinting | 0.76013128 |
| 135 | MP0000749_muscle_degeneration | 0.75586362 |
| 136 | MP0001958_emphysema | 0.72696233 |
| 137 | MP0003632_abnormal_nervous_system | 0.71454224 |
| 138 | MP0000538_abnormal_urinary_bladder | 0.70523071 |
| 139 | MP0003137_abnormal_impulse_conducting | 0.68568849 |
| 140 | MP0004134_abnormal_chest_morphology | 0.68121180 |
| 141 | MP0005410_abnormal_fertilization | 0.68117261 |
| 142 | MP0005195_abnormal_posterior_eye | 0.67688268 |
| 143 | MP0000049_abnormal_middle_ear | 0.66735185 |
| 144 | MP0003690_abnormal_glial_cell | 0.66340343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic cysts (HP:0001737) | 4.14621447 |
| 2 | Chronic hepatic failure (HP:0100626) | 3.97066988 |
| 3 | Focal motor seizures (HP:0011153) | 3.92017400 |
| 4 | Pheochromocytoma (HP:0002666) | 3.79685277 |
| 5 | Neuroendocrine neoplasm (HP:0100634) | 3.40535044 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.36940167 |
| 7 | Atonic seizures (HP:0010819) | 3.36488291 |
| 8 | Medial flaring of the eyebrow (HP:0010747) | 3.35448328 |
| 9 | Hypothermia (HP:0002045) | 3.30943809 |
| 10 | Gait imbalance (HP:0002141) | 3.16941374 |
| 11 | Occipital encephalocele (HP:0002085) | 3.11319504 |
| 12 | Abnormality of the renal medulla (HP:0100957) | 3.09504009 |
| 13 | Vaginal atresia (HP:0000148) | 3.00691967 |
| 14 | Congenital primary aphakia (HP:0007707) | 2.99743046 |
| 15 | Genital tract atresia (HP:0001827) | 2.97356370 |
| 16 | Myokymia (HP:0002411) | 2.97296323 |
| 17 | Rhinitis (HP:0012384) | 2.92509593 |
| 18 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.88403282 |
| 19 | Nephrogenic diabetes insipidus (HP:0009806) | 2.88197816 |
| 20 | Focal seizures (HP:0007359) | 2.76396995 |
| 21 | Cystic liver disease (HP:0006706) | 2.66334762 |
| 22 | Neurofibrillary tangles (HP:0002185) | 2.59948870 |
| 23 | Abnormality of the renal cortex (HP:0011035) | 2.55857237 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 2.55372765 |
| 25 | Megalencephaly (HP:0001355) | 2.49648669 |
| 26 | Absence seizures (HP:0002121) | 2.47207205 |
| 27 | Postaxial foot polydactyly (HP:0001830) | 2.46846177 |
| 28 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.45669060 |
| 29 | Keratoconus (HP:0000563) | 2.43439008 |
| 30 | Increased corneal curvature (HP:0100692) | 2.43439008 |
| 31 | Retinal dysplasia (HP:0007973) | 2.40973230 |
| 32 | Short tibia (HP:0005736) | 2.40651475 |
| 33 | Acute necrotizing encephalopathy (HP:0006965) | 2.37199033 |
| 34 | Hepatocellular necrosis (HP:0001404) | 2.36525301 |
| 35 | Bifid tongue (HP:0010297) | 2.36191430 |
| 36 | Abnormal hair whorl (HP:0010721) | 2.35439280 |
| 37 | Tubulointerstitial abnormality (HP:0001969) | 2.35167205 |
| 38 | Aplasia involving bones of the extremities (HP:0009825) | 2.33965655 |
| 39 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.33965655 |
| 40 | Aplasia of the phalanges of the hand (HP:0009802) | 2.33965655 |
| 41 | Tubulointerstitial nephritis (HP:0001970) | 2.33593696 |
| 42 | Febrile seizures (HP:0002373) | 2.31637069 |
| 43 | Dialeptic seizures (HP:0011146) | 2.30718522 |
| 44 | Sclerocornea (HP:0000647) | 2.29909458 |
| 45 | Visual hallucinations (HP:0002367) | 2.29728219 |
| 46 | Tubular atrophy (HP:0000092) | 2.27412723 |
| 47 | Supranuclear gaze palsy (HP:0000605) | 2.25991217 |
| 48 | Increased CSF lactate (HP:0002490) | 2.24609536 |
| 49 | Increased circulating renin level (HP:0000848) | 2.22618632 |
| 50 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.22013995 |
| 51 | Acute encephalopathy (HP:0006846) | 2.19063170 |
| 52 | Type II lissencephaly (HP:0007260) | 2.18768134 |
| 53 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.18629219 |
| 54 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.18629219 |
| 55 | Hepatic necrosis (HP:0002605) | 2.18151560 |
| 56 | Abnormal ciliary motility (HP:0012262) | 2.17483176 |
| 57 | Hypomagnesemia (HP:0002917) | 2.17183429 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16458701 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.14416141 |
| 60 | Metaphyseal dysplasia (HP:0100255) | 2.13216905 |
| 61 | Congenital hepatic fibrosis (HP:0002612) | 2.10719250 |
| 62 | Hyperventilation (HP:0002883) | 2.10623564 |
| 63 | Delayed gross motor development (HP:0002194) | 2.10550616 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09141976 |
| 65 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.07877653 |
| 66 | Methylmalonic acidemia (HP:0002912) | 2.06658342 |
| 67 | Ankle clonus (HP:0011448) | 2.06519933 |
| 68 | Molar tooth sign on MRI (HP:0002419) | 2.06403680 |
| 69 | Abnormality of midbrain morphology (HP:0002418) | 2.06403680 |
| 70 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.06359779 |
| 71 | Poor coordination (HP:0002370) | 2.02394150 |
| 72 | Poor speech (HP:0002465) | 2.01531779 |
| 73 | Left ventricular hypertrophy (HP:0001712) | 2.01101103 |
| 74 | Nephronophthisis (HP:0000090) | 2.00542689 |
| 75 | Absent/shortened dynein arms (HP:0200106) | 1.99135860 |
| 76 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99135860 |
| 77 | True hermaphroditism (HP:0010459) | 1.99106451 |
| 78 | Renal cortical cysts (HP:0000803) | 1.98383168 |
| 79 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.97755180 |
| 80 | Hypsarrhythmia (HP:0002521) | 1.96585157 |
| 81 | Abnormality of renal resorption (HP:0011038) | 1.96337902 |
| 82 | Abnormal drinking behavior (HP:0030082) | 1.94504619 |
| 83 | Polydipsia (HP:0001959) | 1.94504619 |
| 84 | Abnormality of dentin (HP:0010299) | 1.94090177 |
| 85 | Progressive inability to walk (HP:0002505) | 1.93898745 |
| 86 | Anencephaly (HP:0002323) | 1.92403322 |
| 87 | Follicular hyperkeratosis (HP:0007502) | 1.91806198 |
| 88 | Broad foot (HP:0001769) | 1.91793918 |
| 89 | Scanning speech (HP:0002168) | 1.91356001 |
| 90 | Cerebellar dysplasia (HP:0007033) | 1.91213464 |
| 91 | Specific learning disability (HP:0001328) | 1.90475401 |
| 92 | Male pseudohermaphroditism (HP:0000037) | 1.88320420 |
| 93 | Pancreatic fibrosis (HP:0100732) | 1.88146801 |
| 94 | Progressive macrocephaly (HP:0004481) | 1.86976336 |
| 95 | Menstrual irregularities (HP:0000858) | 1.85412853 |
| 96 | Hyperglycinemia (HP:0002154) | 1.84826674 |
| 97 | Cutaneous finger syndactyly (HP:0010554) | 1.83080021 |
| 98 | Increased serum pyruvate (HP:0003542) | 1.82381208 |
| 99 | Abnormality of glycolysis (HP:0004366) | 1.82381208 |
| 100 | Decreased testicular size (HP:0008734) | 1.82181285 |
| 101 | Abnormality of permanent molar morphology (HP:0011071) | 1.82131328 |
| 102 | Abnormality of the dental root (HP:0006486) | 1.82131328 |
| 103 | Taurodontia (HP:0000679) | 1.82131328 |
| 104 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.81856765 |
| 105 | Agitation (HP:0000713) | 1.81292254 |
| 106 | Furrowed tongue (HP:0000221) | 1.80847291 |
| 107 | Truncal ataxia (HP:0002078) | 1.80846032 |
| 108 | Insidious onset (HP:0003587) | 1.80244753 |
| 109 | Termporal pattern (HP:0011008) | 1.80244753 |
| 110 | Prominent nasal bridge (HP:0000426) | 1.79677928 |
| 111 | Abnormality of the corticospinal tract (HP:0002492) | 1.78946014 |
| 112 | Narrow forehead (HP:0000341) | 1.77163441 |
| 113 | Abnormality of magnesium homeostasis (HP:0004921) | 1.77009280 |
| 114 | Limb dystonia (HP:0002451) | 1.76556266 |
| 115 | Hypoplasia of the brainstem (HP:0002365) | 1.76288555 |
| 116 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.76288555 |
| 117 | Abnormality of the dental pulp (HP:0006479) | 1.76010625 |
| 118 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.75770153 |
| 119 | Cutaneous syndactyly (HP:0012725) | 1.74481905 |
| 120 | Oculomotor apraxia (HP:0000657) | 1.73781658 |
| 121 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.73342379 |
| 122 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.73342379 |
| 123 | Abnormal biliary tract physiology (HP:0012439) | 1.73151955 |
| 124 | Bile duct proliferation (HP:0001408) | 1.73151955 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.72746127 |
| 126 | Postaxial hand polydactyly (HP:0001162) | 1.72363514 |
| 127 | Lower limb muscle weakness (HP:0007340) | 1.72295745 |
| 128 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71569145 |
| 129 | Abnormality of molar (HP:0011077) | 1.71159767 |
| 130 | Abnormality of molar morphology (HP:0011070) | 1.71159767 |
| 131 | Lissencephaly (HP:0001339) | 1.70758133 |
| 132 | Anxiety (HP:0000739) | 1.70595300 |
| 133 | Preaxial hand polydactyly (HP:0001177) | 1.70559707 |
| 134 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.70128731 |
| 135 | Mitochondrial inheritance (HP:0001427) | 1.69896239 |
| 136 | Generalized tonic-clonic seizures (HP:0002069) | 1.68795982 |
| 137 | Broad-based gait (HP:0002136) | 1.68386740 |
| 138 | Polyphagia (HP:0002591) | 1.67862329 |
| 139 | Optic disc pallor (HP:0000543) | 1.67620081 |
| 140 | Thickened helices (HP:0000391) | 1.67121223 |
| 141 | Narrow nasal bridge (HP:0000446) | 1.66992461 |
| 142 | Renal Fanconi syndrome (HP:0001994) | 1.66554387 |
| 143 | Astigmatism (HP:0000483) | 1.66347305 |
| 144 | Myelomeningocele (HP:0002475) | 1.66182233 |
| 145 | Increased hepatocellular lipid droplets (HP:0006565) | 1.65878410 |
| 146 | Fibular hypoplasia (HP:0003038) | 1.65312917 |
| 147 | Abnormality of macular pigmentation (HP:0008002) | 1.64937759 |
| 148 | Chronic bronchitis (HP:0004469) | 1.64696927 |
| 149 | Fibular aplasia (HP:0002990) | 1.63231182 |
| 150 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.61483540 |
| 151 | Aganglionic megacolon (HP:0002251) | 1.60868537 |
| 152 | Cerebral edema (HP:0002181) | 1.58355421 |
| 153 | Lipid accumulation in hepatocytes (HP:0006561) | 1.57640012 |
| 154 | Muscular hypotonia of the trunk (HP:0008936) | 1.57193775 |
| 155 | Short foot (HP:0001773) | 1.56499463 |
| 156 | Inability to walk (HP:0002540) | 1.54360896 |
| 157 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.53636494 |
| 158 | Multicystic kidney dysplasia (HP:0000003) | 1.53258330 |
| 159 | Supernumerary spleens (HP:0009799) | 1.52135533 |
| 160 | Dental crowding (HP:0000678) | 1.50846275 |
| 161 | Attenuation of retinal blood vessels (HP:0007843) | 1.50729857 |
| 162 | Pachygyria (HP:0001302) | 1.50611988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 3.81450302 |
| 2 | MAP4K2 | 3.74397374 |
| 3 | CASK | 3.17550145 |
| 4 | NTRK3 | 3.09859340 |
| 5 | TNIK | 2.93867705 |
| 6 | WNK4 | 2.79480825 |
| 7 | EPHA4 | 2.73467509 |
| 8 | MUSK | 2.44449612 |
| 9 | STK39 | 2.29627590 |
| 10 | MAP2K7 | 2.21483478 |
| 11 | BCR | 2.21006006 |
| 12 | SIK3 | 2.19038462 |
| 13 | MINK1 | 2.14008194 |
| 14 | PRPF4B | 2.09466607 |
| 15 | MARK1 | 2.04750456 |
| 16 | MAPK13 | 1.99800721 |
| 17 | OXSR1 | 1.93213624 |
| 18 | INSRR | 1.83006217 |
| 19 | PNCK | 1.81303015 |
| 20 | NUAK1 | 1.79639714 |
| 21 | SGK494 | 1.71694847 |
| 22 | SGK223 | 1.71694847 |
| 23 | BMPR1B | 1.65461993 |
| 24 | LIMK1 | 1.63864408 |
| 25 | MAP3K4 | 1.62736817 |
| 26 | PRKD3 | 1.62131187 |
| 27 | ARAF | 1.52267937 |
| 28 | PINK1 | 1.51968710 |
| 29 | NTRK1 | 1.46806741 |
| 30 | PHKG1 | 1.45715636 |
| 31 | PHKG2 | 1.45715636 |
| 32 | BCKDK | 1.44256883 |
| 33 | MAP3K12 | 1.44120353 |
| 34 | WNK3 | 1.37753005 |
| 35 | CDK19 | 1.35914952 |
| 36 | NTRK2 | 1.32263915 |
| 37 | PLK2 | 1.30708551 |
| 38 | MST4 | 1.29388496 |
| 39 | KSR2 | 1.28426304 |
| 40 | DYRK2 | 1.25598419 |
| 41 | LMTK2 | 1.22062870 |
| 42 | ZAK | 1.21516095 |
| 43 | SRPK1 | 1.20863743 |
| 44 | BRAF | 1.18985991 |
| 45 | MAP3K9 | 1.17048163 |
| 46 | EIF2AK3 | 1.16916620 |
| 47 | PAK3 | 1.16583850 |
| 48 | UHMK1 | 1.15901423 |
| 49 | WNK1 | 1.15315362 |
| 50 | SGK2 | 1.12964135 |
| 51 | CAMKK2 | 1.05891750 |
| 52 | CCNB1 | 1.04307457 |
| 53 | GRK1 | 1.01642287 |
| 54 | PRKCE | 1.01085262 |
| 55 | MAPKAPK5 | 1.00991674 |
| 56 | PBK | 1.00685197 |
| 57 | KSR1 | 1.00163445 |
| 58 | AKT3 | 0.99125025 |
| 59 | MAP3K2 | 0.98896265 |
| 60 | DYRK3 | 0.98165108 |
| 61 | TESK1 | 0.98004080 |
| 62 | FLT3 | 0.97092327 |
| 63 | CDK5 | 0.93886102 |
| 64 | CSNK1G2 | 0.93581030 |
| 65 | CAMK2A | 0.91068582 |
| 66 | MAPK15 | 0.90063456 |
| 67 | PAK6 | 0.86687343 |
| 68 | PTK2B | 0.86650139 |
| 69 | CAMK2B | 0.84419422 |
| 70 | ADRBK1 | 0.82755894 |
| 71 | MYLK | 0.82377941 |
| 72 | STK38L | 0.81931838 |
| 73 | BMPR2 | 0.81009387 |
| 74 | EPHA3 | 0.79590809 |
| 75 | STK16 | 0.79137421 |
| 76 | DYRK1A | 0.79025613 |
| 77 | PRKCG | 0.78767805 |
| 78 | PDK2 | 0.77540485 |
| 79 | GRK5 | 0.77361634 |
| 80 | CSNK1G3 | 0.77178876 |
| 81 | CDK14 | 0.76731500 |
| 82 | CAMK2D | 0.75659608 |
| 83 | ADRBK2 | 0.74821916 |
| 84 | NEK1 | 0.73526676 |
| 85 | ROCK2 | 0.72880686 |
| 86 | NEK6 | 0.72260392 |
| 87 | ERBB3 | 0.70910278 |
| 88 | VRK1 | 0.70822703 |
| 89 | CDK18 | 0.70817138 |
| 90 | PLK4 | 0.70044549 |
| 91 | OBSCN | 0.68027668 |
| 92 | FER | 0.64071277 |
| 93 | MAP3K6 | 0.63350714 |
| 94 | CSNK1A1L | 0.63305545 |
| 95 | CAMK1G | 0.62056544 |
| 96 | MAP2K4 | 0.62032442 |
| 97 | CDK15 | 0.59910228 |
| 98 | MET | 0.57649141 |
| 99 | PIK3CA | 0.57319455 |
| 100 | ACVR1B | 0.56592174 |
| 101 | BUB1 | 0.56219343 |
| 102 | RET | 0.55636080 |
| 103 | GRK7 | 0.55531386 |
| 104 | SGK3 | 0.55384987 |
| 105 | MAPKAPK3 | 0.55262749 |
| 106 | MAP3K13 | 0.55189310 |
| 107 | LATS1 | 0.54493445 |
| 108 | CDK11A | 0.53958567 |
| 109 | STK3 | 0.53461617 |
| 110 | PIK3CG | 0.51675455 |
| 111 | MKNK1 | 0.50304185 |
| 112 | CAMK2G | 0.48590973 |
| 113 | MAP2K1 | 0.47813255 |
| 114 | ROCK1 | 0.47311245 |
| 115 | MKNK2 | 0.47064372 |
| 116 | DDR2 | 0.46635799 |
| 117 | TAOK3 | 0.45992376 |
| 118 | FRK | 0.45698523 |
| 119 | MARK2 | 0.45589251 |
| 120 | STK24 | 0.44875306 |
| 121 | NEK9 | 0.44713483 |
| 122 | TGFBR1 | 0.43616079 |
| 123 | PLK1 | 0.43291840 |
| 124 | CDC42BPA | 0.43040087 |
| 125 | YES1 | 0.42763936 |
| 126 | PRKCH | 0.42641609 |
| 127 | PRKG1 | 0.42258158 |
| 128 | SGK1 | 0.41884486 |
| 129 | FGFR1 | 0.41220118 |
| 130 | ERBB4 | 0.40061920 |
| 131 | FGFR2 | 0.38558773 |
| 132 | TSSK6 | 0.38398547 |
| 133 | BRSK2 | 0.37980241 |
| 134 | CSNK1G1 | 0.37850026 |
| 135 | PRKACA | 0.37760768 |
| 136 | CSNK1A1 | 0.37634344 |
| 137 | PRKCQ | 0.37350973 |
| 138 | WEE1 | 0.36340738 |
| 139 | DAPK2 | 0.36193139 |
| 140 | PLK3 | 0.36085640 |
| 141 | EPHB2 | 0.33802039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67742060 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.63511701 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.49467886 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.46198233 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31148672 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.12163193 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.11064968 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.08343379 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.08224001 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.06874002 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.06253498 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.03773153 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.01811849 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94926867 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.94612291 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.92063505 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.90166386 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.85358398 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85058804 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82556292 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.81335086 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.78515059 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.77861477 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.73748044 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.69880657 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.69186996 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68827029 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.64826132 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.64744488 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61795415 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.57821119 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55062958 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53186366 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.52287244 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51642467 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50623245 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.45343984 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35504132 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.32336711 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30990057 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29130706 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26625803 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25865541 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.23688220 |
| 45 | RNA polymerase_Homo sapiens_hsa03020 | 1.22040586 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18806050 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.18591859 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17808821 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 1.14569671 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13603225 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12415720 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11318704 |
| 53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08935549 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 1.07924306 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07543025 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04063452 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00250644 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99824271 |
| 59 | Gap junction_Homo sapiens_hsa04540 | 0.98464782 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97873576 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.97725369 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95342923 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94503135 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93787140 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93578376 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87180469 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87153296 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84430418 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81102693 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80429635 |
| 71 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80234175 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78722409 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78522804 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.78119692 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77635763 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76724235 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76693612 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76418167 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76019798 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.74834418 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74748973 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74698160 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74166639 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73343882 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73133827 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73084172 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72702368 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72538135 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71567614 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70788142 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70747417 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.70338308 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69857320 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69819309 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69479287 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67575403 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.66602097 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66392939 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.65006521 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64583964 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64448331 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62832117 |
| 103 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62268166 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62262856 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60159076 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.59087899 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58265941 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57831673 |
| 109 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57429792 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57364360 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55735225 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55398924 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55359738 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54145940 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54049037 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53924024 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53168695 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52324110 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52163213 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50911223 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50050924 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50025071 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49875547 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.48495200 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48002487 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46995340 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46976316 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46395557 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45922724 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44210674 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43336620 |
| 132 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42518279 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.40968094 |
| 134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40537390 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40428909 |
| 136 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40282862 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39500649 |
| 138 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39357059 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.39142077 |
| 140 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39133666 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39110850 |
| 142 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38959730 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37997940 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37925043 |
| 145 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37758366 |
| 146 | Glioma_Homo sapiens_hsa05214 | 0.37317303 |

